These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19010975)

  • 41. The analgesia effect of duloxetine on post-operative pain via intrathecal or intraperitoneal administration.
    Sun YH; Li HS; Zhu C; Hu W; Yang J; Zhao GL; Lu GJ; Wu SX; Dong YL
    Neurosci Lett; 2014 May; 568():6-11. PubMed ID: 24686187
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alpha2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving rats.
    Gobert A; Rivet JM; Cistarelli L; Melon C; Millan MJ
    J Neurochem; 1997 Dec; 69(6):2616-9. PubMed ID: 9375697
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [FDA approval for the antidepressive drug Cymbalta].
    Krankenpfl J; 2004; 42(5-6):154. PubMed ID: 15527218
    [No Abstract]   [Full Text] [Related]  

  • 44. [Duloxetine reduces pain and depression].
    Krankenpfl J; 2004; 42(7-10):246-7. PubMed ID: 15675408
    [No Abstract]   [Full Text] [Related]  

  • 45. Innovations in pharmacotherapy for stress urinary incontinence.
    Cannon TW; Yoshimura N; Chancellor MB
    Int Urogynecol J Pelvic Floor Dysfunct; 2003 Dec; 14(6):367-72. PubMed ID: 14676995
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Duloxetine pharmacology: profile of a dual monoamine modulator.
    Karpa KD; Cavanaugh JE; Lakoski JM
    CNS Drug Rev; 2002; 8(4):361-76. PubMed ID: 12481192
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Duloxetine: a dual reuptake inhibitor.
    Dugan SE; Fuller MA
    Ann Pharmacother; 2004 Dec; 38(12):2078-85. PubMed ID: 15522980
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Simultaneous increases of extracellular monoamines in microdialysates from hypothalamus of conscious rats by duloxetine, a dual serotonin and norepinephrine uptake inhibitor.
    Engleman EA; Perry KW; Mayle DA; Wong DT
    Neuropsychopharmacology; 1995 Jul; 12(4):287-95. PubMed ID: 7576005
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Manic switching in patients receiving duloxetine.
    de Dios C; Ezquiaga E
    Am J Psychiatry; 2007 Jul; 164(7):1121. PubMed ID: 17606669
    [No Abstract]   [Full Text] [Related]  

  • 50. Duloxetine-induced cutaneous adverse reaction.
    Oulis P; Masdrakis VG; Karakatsanis NA; Karapoulios E; Kouzoupis AV; Soldatos CR
    J Clin Psychopharmacol; 2008 Feb; 28(1):104-5. PubMed ID: 18204353
    [No Abstract]   [Full Text] [Related]  

  • 51. The use of Duloxetine in the treatment of male stress urinary incontinence.
    Fink KG; Huber J; Würnschimmel E; Schmeller NT
    Wien Med Wochenschr; 2008; 158(3-4):116-8. PubMed ID: 18330528
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A challenge].
    Krankenpfl J; 2005; 43(4-6):93. PubMed ID: 16171044
    [No Abstract]   [Full Text] [Related]  

  • 53. Duloxetine in major depressed patients resistant to SSRIs and/or venlafaxine.
    Pitchot W; Scantamburlo G; Ansseau M
    Psychiatr Danub; 2010 Nov; 22 Suppl 1():S106-7. PubMed ID: 21057413
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial.
    Goldstein DJ; Mallinckrodt C; Lu Y; Demitrack MA
    J Clin Psychiatry; 2002 Mar; 63(3):225-31. PubMed ID: 11926722
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Digging for data on harms in duloxetine trials.
    Doshi P; Zito J; dosReis S
    BMJ; 2014 Jun; 348():g3578. PubMed ID: 24904123
    [No Abstract]   [Full Text] [Related]  

  • 56. Efficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorder.
    Thase ME; Pritchett YL; Ossanna MJ; Swindle RW; Xu J; Detke MJ
    J Clin Psychopharmacol; 2007 Dec; 27(6):672-6. PubMed ID: 18004135
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combining mirtazapine and duloxetine in treatment-resistant depression improves outcomes and sexual function.
    Ravindran LN; Eisfeld BS; Kennedy SH
    J Clin Psychopharmacol; 2008 Feb; 28(1):107-8. PubMed ID: 18204355
    [No Abstract]   [Full Text] [Related]  

  • 58. Duloxetine treatment of social anxiety disorder with comorbid major depression.
    Lin CC
    J Clin Psychopharmacol; 2008 Oct; 28(5):591-2; author reply 592-3. PubMed ID: 18794669
    [No Abstract]   [Full Text] [Related]  

  • 59. Burning paresthesia related to duloxetine therapy.
    Woo YS; Bahk WM
    J Clin Psychopharmacol; 2014 Jun; 34(3):392-4. PubMed ID: 24633002
    [No Abstract]   [Full Text] [Related]  

  • 60. Recurrent episodes of serotonin-reuptake inhibitor-mediated hyponatremia in an elderly patient.
    Stovall R; Brahm NC; Crosby KM
    Consult Pharm; 2009 Oct; 24(10):765-8. PubMed ID: 20017411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.